PCV31 COST-EFFECTIVENESS OF EVOLOCUMAB FOR THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLEMIA IN THE KINGDOM OF SAUDI ARABIA

Journal article

Open access

Peer reviewed

A. Alghamdi, B. Balkhi, A. Altowaijri, N. Alshehri, K.F. AlHabib, L. Ralph, E.R. Marriott, J. Garcia Perlaza, F. al-Janad and R. Aziziyeh

Value in health, Vol.23, pp.S95-S96

05/2020

Files and links (1)

url

https://doi.org/10.1016/j.jval.2020.04.136View

Published (Version of record) Open

1 Record Views

Title: PCV31 COST-EFFECTIVENESS OF EVOLOCUMAB FOR THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLEMIA IN THE KINGDOM OF SAUDI ARABIA
Creators - without role: A. Alghamdi - King Saud University
B. Balkhi - King Saud University
A. Altowaijri - King Saud University
N. Alshehri - Riyadh Armed Forces Hospital
K.F. AlHabib - King Saud University
L. Ralph - BresMed
E.R. Marriott - BresMed
J. Garcia Perlaza - The Thousand
F. al-Janad - Amgen
R. Aziziyeh - Amgen
Publication Details: Value in health, Vol.23, pp.S95-S96
Publisher: Elsevier Inc
Identifiers: 9951513508331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article